Core Viewpoint - The company reported a significant increase in revenue but also experienced a rise in losses, indicating challenges in profitability despite sales growth [1] Financial Performance - Revenue for the six months ending September 30, 2025, was HKD 51.738 million, representing an approximate 59% year-on-year increase [1] - The loss attributable to shareholders was HKD 35.509 million, which is a 31.65% increase compared to the previous year [1] - The loss per share was HKD 0.0261 [1] Revenue Drivers - The revenue growth was primarily driven by increased sales in the building materials and health, medical, and leisure segments [1] - The net impact of reduced property deliveries from the Yangzhong project for the six months ending September 30, 2024, also contributed to the revenue increase [1] Cost Factors - The increase in net losses was mainly due to a decrease in gross profit and an increase in financial costs [1]
保集健康(01246)公布中期业绩 公司拥有人应占亏损3550.9万港元 同比增长31.65%